Magnolia Capital Advisors’s DexCom DXCM Stock Holding History

Magnolia Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$735K	Buy	10,910 +169	+2%	+$11.3K	0.13%	174
2026 Q1	$675K	Buy	10,741 +485	+5%	+$33.8K	0.13%	177
2025 Q4	$681K	Sell	10,256 -1,886	-16%	-$122K	0.14%	147
2025 Q3	$817K	Buy	12,142 +88	+0.7%	+$6.96K	0.21%	120
2025 Q2	$1.05M	Sell	12,054 -679	-5%	-$53.2K	0.26%	103
2025 Q1	$870K	Buy	12,733 +1,386	+12%	+$113K	0.24%	107
2024 Q4	$882K	Buy	11,347 +3,359	+42%	+$249K	0.23%	111
2024 Q3	$536K	Buy	7,988 +3,313	+71%	+$272K	0.27%	93
2024 Q2	$530K	Buy	+4,675	New	+$591K	0.3%	82

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Magnolia Capital Advisors's DXCM Position: Q2 2026 in Review

Magnolia Capital Advisors increased its DexCom (DXCM) stake by 1.6% in Q2 2026, buying an estimated $11.3K and bringing the position to 10,910 shares worth $735K. The position accounts for 0.13% of the portfolio, ranked #174.

Magnolia Capital Advisors first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.05M in Q2 2025. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Magnolia Capital Advisors held 10,910 shares of DexCom worth $735K as of Q2 2026.
Magnolia Capital Advisors bought 169 DexCom shares in Q2 2026, an estimated $11.3K.
DexCom made up 0.13% of Magnolia Capital Advisors's portfolio in Q2 2026, its #174 holding.
Magnolia Capital Advisors first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
Magnolia Capital Advisors's DexCom position peaked at $1.05M in Q2 2025.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.